ID

34205

Beschrijving

A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01326000

Link

https://clinicaltrials.gov/show/NCT01326000

Trefwoorden

  1. 15-01-19 15-01-19 -
  2. 14-05-19 14-05-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

15 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Colorectal Cancer NCT01326000

Eligibility Colorectal Cancer NCT01326000

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/= 18 years of age
Beschrijving

ID.1

Datatype

boolean

carcinoma of the colon and/or rectum
Beschrijving

ID.2

Datatype

boolean

disease progression during or within 6 months of last dose of oxaliplatin containing first-line combination therapy for metastatic disease
Beschrijving

ID.3

Datatype

boolean

ecog performance status 0-1
Beschrijving

ID.4

Datatype

boolean

adequate hematological, renal and liver function
Beschrijving

ID.5

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with monoclonal antibody/small molecule against epidermal growth factor receptor (egfr)
Beschrijving

ID.6

Datatype

boolean

prior treatment with irinotecan
Beschrijving

ID.7

Datatype

boolean

radiotherapy within the last 4 weeks before first dose of study drug (except for limited field palliative radiotherapy for bone pain relief)
Beschrijving

ID.8

Datatype

boolean

cns metastasis
Beschrijving

ID.9

Datatype

boolean

history of or active autoimmune disorders/conditions
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Colorectal Cancer NCT01326000

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, >/= 18 years of age
boolean
ID.2
Item
carcinoma of the colon and/or rectum
boolean
ID.3
Item
disease progression during or within 6 months of last dose of oxaliplatin containing first-line combination therapy for metastatic disease
boolean
ID.4
Item
ecog performance status 0-1
boolean
ID.5
Item
adequate hematological, renal and liver function
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
prior treatment with monoclonal antibody/small molecule against epidermal growth factor receptor (egfr)
boolean
ID.7
Item
prior treatment with irinotecan
boolean
ID.8
Item
radiotherapy within the last 4 weeks before first dose of study drug (except for limited field palliative radiotherapy for bone pain relief)
boolean
ID.9
Item
cns metastasis
boolean
ID.10
Item
history of or active autoimmune disorders/conditions
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial